scholarly journals Impact of obstructive sleep apnoea on diabetes and cardiovascular disease

2013 ◽  
Vol 199 (S8) ◽  
Author(s):  
Garun S Hamilton ◽  
Matthew T Naughton
Keyword(s):  
Cardiovascular Disease ◽  
Obstructive Sleep Apnoea ◽  
Sleep Apnoea ◽  
Obstructive Sleep

scholarly journals Sleeping Beauty or the Beast? – The Metabolic Syndrome from an Obstructive Sleep Apnoea Perspective

2010 ◽  
Vol 9 (1) ◽  
pp. 12 ◽  
Author(s):  
Lise Tarnow ◽  
Brigitte Klinkenbijl ◽  
Holger Woehrle ◽  
◽  
◽  
...  
Keyword(s):  
Heart Failure ◽  
Cardiovascular Disease ◽  
Metabolic Syndrome ◽  
Obstructive Sleep Apnoea ◽  
Reduce Blood Pressure ◽  
Sleep Apnoea ◽  
Sleeping Beauty ◽  
The Metabolic Syndrome ◽  
Home Based ◽  
Obstructive Sleep

Obstructive sleep apnoea (OSA) is a significant health issue. Patients with cardiovascular disease as well as patients with diabetes have a high prevalence of OSA, and the prevalence of coronary heart disease, heart failure, stroke and diabetes is increased in patients with obstructive sleep apnoea. Physiological responses to OSA include sympathetic activation, neurohumoral changes and inflammation, all of which are precursors for cardiovascular disease and diabetes. International guidelines are starting to recognise the importance of OSA for patients with cardiovascular conditions such as heart failure and hypertension. Diagnosis is important, and home-based sleep testing devices can facilitate this process. Treating OSA with continuous positive airway pressure (CPAP) has been shown to reduce blood pressure (BP) in patients with hypertension, but more research is needed to determine which components of the metabolic syndrome respond best to the addition of CPAP therapy.

scholarly journals Obstructive sleep apnoea and cardiovascular disease in the developing world

2015 ◽  
Vol 21 (1) ◽  
pp. 2
Author(s):  
Richard Raine
Keyword(s):  
Cardiovascular Disease ◽  
Obstructive Sleep Apnoea ◽  
Developing World ◽  
Sleep Apnoea ◽  
Common Condition ◽  
Obstructive Sleep ◽  
The World ◽  
The Usa

<p>Obstructive sleep apnoea (OSA) is a common condition, with studies from the USA suggesting that the prevalence is 4% in men and 2% in women.[1] The prevalence in other parts of the world is unknown but is likely to be similar.</p>

How important is sleep for cardiac health?

2021 ◽  
pp. 1-3
Author(s):  
Andrew Richardson
Keyword(s):  
Cardiovascular Disease ◽  
Obstructive Sleep Apnoea ◽  
Sleep Apnoea ◽  
British Association ◽  
Cardiac Health ◽  
Obstructive Sleep ◽  
Cardiovascular Care

Andrew Richardson, educational advisor for the British Association for Nursing in Cardiovascular Care, discusses the link between obstructive sleep apnoea and cardiovascular disease.

Obstructive sleep apnoea and cardiovascular disease

2004 ◽  
Vol 34 (7) ◽  
pp. 420-426 ◽  
Author(s):  
G. S. Hamilton ◽  
P. Solin ◽  
M. T. Naughton
Keyword(s):  
Cardiovascular Disease ◽  
Obstructive Sleep Apnoea ◽  
Sleep Apnoea ◽  
Obstructive Sleep

scholarly journals Atherogenic Index of Plasma in Obstructive Sleep Apnoea

2021 ◽  
Vol 10 (3) ◽  
pp. 417
Author(s):  
Andras Bikov ◽  
Martina Meszaros ◽  
Laszlo Kunos ◽  
Alina Gabriela Negru ◽  
Stefan Marian Frent ◽  
...  
Keyword(s):  
Cardiovascular Disease ◽  
Disease Severity ◽  
Obstructive Sleep Apnoea ◽  
Sleep Apnoea ◽  
Atherogenic Index ◽  
Clinical Value ◽  
Sleep Study ◽  
Atherogenic Index Of Plasma ◽  
Obstructive Sleep ◽  
Cardiovascular Morbidity And Mortality

Background: Dyslipidaemia is well recognised in obstructive sleep apnoea (OSA) and could contribute to the development of cardiovascular disease (CVD). Atherogenic index of plasma (AIP) predicts cardiovascular morbidity and mortality better than the individual lipid levels. The aim of this study was to investigate the AIP in patients with OSA in relation with disease severity. Methods: Four hundred sixty-one patients with OSA and 99 controls participated in this study. AIP was assessed in the morning following a diagnostic sleep study. The association between lipid values and OSA were adjusted for age, gender, and body mass index. Results: Patients with OSA had higher AIP and triglyceride, and lower high-density lipoprotein cholesterol (HDL-C) levels (all p < 0.05). AIP significantly correlated with the Epworth Sleepiness Scale score (ρ = 0.19), the apnoea-hypopnoea index (ρ = 0.40) and oxygen desaturation index (ρ = 0.43, all p < 0.05). However, there was no relationship between the AIP and markers of sleep quality such as total sleep time, sleep period time, sleep efficiency, arousal index or percentage of REM sleep (all p > 0.05). AIP was not a better predictor for self-reported cardiovascular disease or diabetes than HDL-C. Conclusions: AIP is elevated in OSA and is related to disease severity. However, it does not seem to have an additional clinical value compared to HDL-C.

Sign in / Sign up

Export Citation Format

Share Document